eBook: Outsourcing — India's Burgeoning Biologics CDMO Marketplace

The biopharmaceutical outsourcing market space is recognized widely as attractive. And yet, despite significant investment in vaccine manufacturing infrastructure catalyzed by the COVID-19 pandemic, Indian contract development and manufacturing organizations have yet to make their mark. No commercial-scale biomanufacturing capacity to match that of other countries is yet in place in India. In this eBook, industry veteran Roger Lias details the reasons for that situation and the trends that are changing India’s biopharmaceutical outlook.

Fill out the form to read the full eBook now.